Supplemental Corticosteroids in Cirrhotic Hypotensive Patients With Suspicion of Sepsis

NCT02602210 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

100

Enrollment

OTHER

Sponsor class

Stopped low inclusion rate

Conditions

Liver Cirrhosis

Interventions

DRUG: Hydrocortisone
DRUG: NaCL 0.9%

Sponsor

Universitaire Ziekenhuizen KU Leuven